Compounds > 2'-5'-oligoadenylate trimer
Page last updated: 2024-09-02

2'-5'-oligoadenylate trimer and Chronic Fatigue and Immune Dysfunction Syndrome

2'-5'-oligoadenylate trimer has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Meirleir, K; El Bakkouri, K; Englebienne, P; Frémont, M; Herst, CV; Vaeyens, F1
Müller, WE; Schröder, HC; Ushijima, H1
Ablashi, DV; Carter, WA; Henry, B; Hitzges, P; Müller, WE; Peterson, DL; Reichenbach, NL; Schröder, HC; Sobol, RW; Suhadolnik, RJ1
Bisbal, C; Campine, I; De Becker, P; De Meirleir, K; Demettre, E; Lebleu, B; Salehzada, T1
Shetzline, SE; Suhadolnik, RJ1

Reviews

1 review(s) available for 2'-5'-oligoadenylate trimer and Chronic Fatigue and Immune Dysfunction Syndrome

ArticleYear
Mechanism of the antiretroviral effect of dsRNA.
    Progress in molecular and subcellular biology, 1994, Volume: 14

    Topics: 2',5'-Oligoadenylate Synthetase; Acquired Immunodeficiency Syndrome; Adenine Nucleotides; AIDS-Related Complex; Animals; Antiviral Agents; Cell Division; eIF-2 Kinase; Endoribonucleases; Enzyme Activation; Fatigue Syndrome, Chronic; HIV Infections; HIV Long Terminal Repeat; HIV-1; Humans; Neoplasms; Oligoribonucleotides; Poly I-C; Protein Serine-Threonine Kinases; RNA, Double-Stranded; Topoisomerase I Inhibitors

1994

Trials

1 trial(s) available for 2'-5'-oligoadenylate trimer and Chronic Fatigue and Immune Dysfunction Syndrome

ArticleYear
Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18 Suppl 1

    Topics: 2',5'-Oligoadenylate Synthetase; Adenine Nucleotides; Antiviral Agents; Endoribonucleases; Fatigue Syndrome, Chronic; Female; Humans; Male; Middle Aged; Oligoribonucleotides; Poly I-C; Poly U; RNA, Double-Stranded; Up-Regulation; Virus Diseases

1994

Other Studies

3 other study(ies) available for 2'-5'-oligoadenylate trimer and Chronic Fatigue and Immune Dysfunction Syndrome

ArticleYear
2',5'-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome.
    Experimental and molecular pathology, 2005, Volume: 78, Issue:3

    Topics: Adenine Nucleotides; Dimerization; Electrophoresis, Polyacrylamide Gel; Endoribonucleases; Enzyme Activation; Fatigue Syndrome, Chronic; Humans; Immunoblotting; Leukocytes, Mononuclear; Oligoribonucleotides; Peptides; Recombinant Proteins; Substrate Specificity

2005
A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome.
    The American journal of medicine, 2000, Volume: 108, Issue:2

    Topics: Adenine Nucleotides; Adult; Biomarkers; Case-Control Studies; Depression; Diagnosis, Differential; Fatigue Syndrome, Chronic; Female; Fibromyalgia; Humans; Male; Middle Aged; Monocytes; Oligoribonucleotides

2000
Characterization of a 2',5'-oligoadenylate (2-5A)-dependent 37-kDa RNase L: azido photoaffinity labeling and 2-5A-dependent activation.
    The Journal of biological chemistry, 2001, Jun-29, Volume: 276, Issue:26

    Topics: Adenine Nucleotides; Adenosine Triphosphate; Azides; Binding Sites; Binding, Competitive; Cell Extracts; Endoribonucleases; Enzyme Activation; Fatigue Syndrome, Chronic; Humans; Kinetics; Leukocytes, Mononuclear; Oligoribonucleotides; Photoaffinity Labels; Poly U

2001